Table 2.
Subgroups | Number of studies | Number of participants | Odds ratio | 95% CI | p‐value |
---|---|---|---|---|---|
Country | |||||
Ethiopia | 1 | 627 | 4.60 | 2.75–7.70 | 0.000 |
Ghana | 1 | 116 | 1.81 | 1.53–2.14 | 0.000 |
Iran | 1 | 394 | 3.31 | 2.07–5.29 | 0.000 |
Nigeria | 1 | 1359 | 2.82 | 1.96–4.05 | 0.000 |
Pakistan | 1 | 367 | 2.58 | 1.64–4.07 | 0.000 |
South Africa | 2 | 1353 | 1.92 | 1.51–2.46 | 0.000 |
USA | 3 | 14,771 | 2.78 | 2.57–3.00 | 0.000 |
Local | |||||
Not Reported | 1 | 14,274 | 2.78 | 2.57–3.01 | 0.000 |
Peri‐Urban | 2 | 1353 | 1.92 | 1.51–2.46 | 0.000 |
Rural | 1 | 627 | 4.60 | 2.75–7.70 | 0.000 |
Urban | 4 | 1007 | 2.46 | 1.76–3.43 | 0.000 |
Urban and Rural | 1 | 1359 | 2.82 | 1.96–4.05 | 0.000 |
Urban slum | 1 | 367 | 2.58 | 1.64–4.07 | 0.000 |
Study design | |||||
Cross‐sectional | 6 | 17,605 | 2.81 | 2.47–3.19 | 0.000 |
Prospective cohort | 4 | 1382 | 2.04 | 1.63–2.54 | 0.000 |
Course life | |||||
Adolescent | 1 | 1359 | 2.82 | 1.96–4.05 | 0.000 |
Adult | 5 | 1374 | 2.45 | 1.87–3.23 | 0.000 |
Adult and adolescent | 2 | 14,901 | 3.34 | 2.08–5.38 | 0.000 |
Not Reported | 2 | 1353 | 1.92 | 1.51–2.46 | 0.000 |
Trimester | |||||
All | 4 | 2236 | 2.46 | 1.80–3.37 | 0.000 |
Not Reported | 4 | 15,714 | 2.31 | 1.80–2.97 | 0.000 |
Second and Third | 2 | 1037 | 3.61 | 2.35–5.55 | 0.000 |